2m 2m 2m 2m 2m 2m 2m
CANOPY GROW (CGC)
NASDAQ
$1.03-$0.04 (-3.30%)
Price as of Jun 03, 2026 7:59 PM EDT- $468.3MMarket Cap
- -12.40%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CANOPY GROW (CGC)
$1.03-$0.04 (-3.30%)
Annual
Quarterly
03/31/2025 | 03/31/2024 | 03/31/2023 | 03/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 269.0M -9.47% | 297.1M -26.25% | 402.9M -22.57% | 520.3M -4.82% | |
Cost of Revenue | 189.5M -12.38% | 216.3M -57.35% | 507.0M -28.92% | 713.4M +48.72% | |
Gross Profit | 79.5M -1.70% | 80.9M +177.67% | -104.1M -46.06% | -193.1M -388.31% | |
Sales and Marketing Expense | 169.6M -26.07% | 229.4M -49.71% | 456.2M -3.50% | 472.8M -17.84% | |
Research and Development Expense | -2.7M -40.53% | -4.6M -78.77% | -21.7M -32.85% | -32.3M -43.83% | |
Depreciation and Amortization Expense | 21.6M -12.92% | 24.8M -10.73% | 27.8M -27.22% | 38.2M -32.08% | |
Total Operating Expenses | 196.7M -36.48% | 309.6M -88.72% | 2.7B +208.46% | 889.6M -32.11% | |
Operating Profit | -117.1M -48.78% | -228.7M -91.97% | -2.8B +163.08% | -1.1B -12.93% | |
Interest Income | 8.8M -45.70% | 16.2M -33.14% | 24.3M +267.85% | 6.6M -69.11% | |
Interest Expense | -74.6M -29.22% | -105.4M -16.49% | -126.2M +21.37% | -103.9M +1,128.80% | |
Interest Income and Expense and Net | -65.8M -26.22% | -89.1M -12.53% | -101.9M +4.66% | -97.3M -854.13% | |
Total Nonoperating Income and Expense | -479.9M +97.76% | -242.6M -47.93% | -466.0M -161.86% | 753.3M +294.22% | |
Income before Taxes | -597.0M +26.66% | -471.4M -85.78% | -3.3B +906.07% | -329.4M -80.44% | |
Income Taxes | 7.1M -42.07% | 12.3M +358.21% | -4.8M -46.65% | -8.9M -31.91% | |
Extraordinary Items | N/A N/A | N/A N/A | 403.6M +51.65% | 266.1M -44.70% | |
Net Income | -598.1M -9.00% | -657.3M -79.95% | -3.3B +984.83% | -302.2M -82.68% | |
Net Income from Continuing Operations Applicable to Common | -597.0M +26.66% | -471.4M -85.78% | -3.3B +906.07% | -329.4M -80.44% | |
Basic EPS and Net Income | -5.56 -36.75% | -8.79 +24.33% | -7.07 +818.18% | -0.77 -83.58% | |
Diluted EPS and Net Income | -5.56 -36.75% | -8.79 +24.33% | -7.07 +818.18% | -0.77 -83.58% | |
Basic Weighted Average Shares | 107.6M +43.81% | 74.8M -83.87% | 463.7M +18.50% | 391.3M +5.29% | |
Diluted Weighted Average Shares | 107.6M +43.81% | 74.8M -83.87% | 463.7M +18.50% | 391.3M +5.29% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 113.8M -33.17% | 170.3M -74.85% | 677.0M -12.76% | 776.0M -32.79% | |
Short-Term Investments | 17.7M -46.76% | 33.2M -68.60% | 105.6M -82.27% | 595.7M -47.96% | |
Cash and Cash Equivalents and Short-Term Investments | 131.5M -35.38% | 203.5M -74.00% | 782.6M -42.94% | 1.4B -40.34% | |
Total Current Assets | 294.6M -20.64% | 371.2M -65.54% | 1.1B -38.00% | 1.7B -38.78% | |
Accumulated Depreciation | 112.0M +14.04% | 98.2M -12.34% | 112.0M -51.91% | 232.9M +4.64% | |
Property and Plant and Equipment and Net | 293.5M -8.30% | 320.1M -35.91% | 499.5M -47.02% | 942.8M -12.26% | |
Total Long-Term Assets | 16.4M -32.09% | 24.1M +21.82% | 19.8M +29.08% | 15.3M +209.25% | |
Total Assets | 917.7M -29.43% | 1.3B -46.69% | 2.4B -56.56% | 5.6B -17.71% | |
Income Taxes Payable | 397,000 -22.46% | 512,000 +43.42% | 357,000 -97.77% | 16.0M -25.20% | |
Total Short-Term Debt | 4.3M -95.90% | 103.9M -81.34% | 556.9M +5,890.64% | 9.3M -5.40% | |
Total Current Liabilities | 94.4M -59.78% | 234.7M -70.80% | 803.8M +277.57% | 212.9M -25.12% | |
Total Long-Term Debt | 299.8M -39.22% | 493.3M -34.23% | 750.0M -49.72% | 1.5B -5.18% | |
Total Long-Term Liabilities | 36.3M -49.49% | 71.8M -42.50% | 124.9M -34.29% | 190.0M +77.22% | |
Total Liabilities | 430.5M -46.18% | 799.8M -52.37% | 1.7B -15.39% | 2.0B -38.01% | |
Retained Earnings | -10.9B +5.79% | -10.3B +6.80% | -9.7B +51.84% | -6.4B +4.98% | |
Total Stockholders Equity | 487.2M -2.63% | 500.4M -34.03% | 758.4M -78.87% | 3.6B +3.11% | |
Total Shares Outstanding | 183.9M +101.79% | 91.1M -82.39% | 517.3M +31.16% | 394.4M +3.02% | |
Cash Flow | |||||
Cash from Operating Activities | -165.8M -41.21% | -281.9M -49.43% | -557.5M +2.15% | -545.8M +17.19% | |
Capital Expenditures | 10.8M +213.51% | 3.4M -62.58% | 9.2M -74.87% | 36.7M -77.70% | |
Cash from Investing Activities | -47.8M -119.78% | 241.6M -44.25% | 433.4M +87.76% | 230.8M +126.11% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 148.7M +131.97% | -465.1M +2,261.40% | -19.7M -56.75% | -45.5M -103.60% | |
Financials Ratio | |||||
Gross Margin | 29.56% +8.59% | 27.22% +205.31% | -25.85% -30.34% | -37.10% -402.90% | |
Operating Margin | -43.55% -43.42% | -76.97% -89.11% | -706.94% +239.75% | -208.08% -8.53% | |
Return on Assets | -53.93% +53.42% | -35.15% -56.82% | -81.40% +1,575.37% | -4.86% -80.95% | |
Return on Equity | -121.13% +15.99% | -104.43% -30.74% | -150.78% +1,664.26% | -8.55% -79.51% | |
Revenue Growth | -9.47% -63.91% | -26.25% +16.32% | -22.57% +368.63% | -4.82% -112.99% | |
Current Ratio | 3.12 +97.32% | 1.58 +18.01% | 1.34 -83.58% | 8.16 -18.25% | |
Cash Ratio | 1.21 +66.15% | 0.73 -13.84% | 0.84 -76.89% | 3.65 -10.24% | |
Debt-to-Equity Ratio | 0.62 -47.71% | 1.19 -30.73% | 1.72 +312.13% | 0.42 -8.03% | |
Debt-to-Assets Ratio | 0.33 -27.87% | 0.46 -14.28% | 0.54 +100.45% | 0.27 +15.22% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow